Results 101 to 110 of about 7,464 (129)

Omeprazole activation of CD4+ and CD8+ T-cells through off-target covalent modification of cellular proteins. [PDF]

Toxicol Sci
Grice S, Albashtawy S, Wells G, Hering L, Adair K, Sarsby J, Brownridge P, Ford M, Lloyd R, Hampson L, Wagner A, Sun Y, Liu H, Hammond S, Meng X, Zhang F, Naisbitt D.   +16 more
europepmc   +1 more source

Associations of non-HLA gene polymorphisms with celiac disease in India. [PDF]

Sci Rep
Ramakrishna BS, Singh A, Srinivasan P, Venugopal G, Gayathri R, Ahmed A, Singh N, Dutta S, Ahuja V, Makharia GK.   +9 more
europepmc   +1 more source

Checkpoint inhibition and beyond: Precision immune engineering for the immune-privileged landscape of ocular malignancies. [PDF]

Bioimpacts
Abuhassan Q, Saleh K, Saleh K, Jyothi SR, Sahoo R, Prakash P, Mukherjee G, Sinha A, Boyqulov T.   +8 more
europepmc   +1 more source

CAR T cell therapy for fighting IPF: perspectives on a living drug. [PDF]

Front Immunol
Sun W, Lu S, Chen T, He Y, Xu Z, Cai Z.
europepmc   +1 more source

The Emerging Roles and Therapeutic Potential of Unconventional T Cells in Sepsis. [PDF]

J Inflamm Res
Gu S, Zhang P, Zhang C, Tang T, Chang T, Dong L, Gao W, Tang Z.   +7 more
europepmc   +1 more source

Cytokine-Engineered Chimeric Antigen Receptor-T Cell Therapy: How to Balance the Efficacy and Toxicity. [PDF]

Adv Sci (Weinh)
Zhang X, Aimaiti G, Guan Y, Sha Y, Zhou W, Shen J, Zhao B, Yuan WE.   +7 more
europepmc   +1 more source

Tolerogenic Therapies in Cardiac Transplantation. [PDF]

Int J Mol Sci
Wolner L, William-Olsson J, Podesser BK, Zuckermann A, Pilat N.   +4 more
europepmc   +1 more source

Redefining the Immunobiology of Organ Transplantation for New Clinical Horizons. [PDF]

Scand J Immunol
Manjili MH.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Minor lymphocyte stimulatory antigen-bearing stimulator cells require lipopolysaccharide activation to induce programmed cell death in T cell hybridomas

Journal of Immunology, 1992
Abstract T cell hybridomas respond to conventional peptide Ag associated with self major histocompatibility restriction elements, as well as to alloantigens, activating lectins, and stimulatory forms of mAb by producing lymphokines and undergoing programmed cell death (PCD).
Huber B T
exaly   +3 more sources

Production of minor lymphocyte stimulatory-1a antigen from activated CD4+ or CD8+ T cells.

The Journal of Immunology, 1993
Abstract Minor lymphocyte stimulatory (Mls) Ag are super Ag that stimulate a high proportion of T cells of a specific TCR V beta family. One of the super Ag, Mls-1a, which is recognized mainly by TCR V beta 6+ and V beta 8.1+ T cells, has recently been linked to the response to product of the open reading frame in 3'-long terminal repeat
N, Arase-Fukushi, H, Arase, K, Ogasawara, R A, Good, K, Onoé   +4 more
openaire   +2 more sources